COVID-19 and Vitamin D (Co-VIVID Study): a systematic review and meta-analysis of randomized controlled trials
Seshadri Reddy Varikasuvu, Balachandar Thangappazham, Hemanth Raj
doi:10.1101/2021.08.22.21262216
Background: Vitamin D levels have been reported to be associated with COVID-19 susceptibility, severity and mortality events.. We performed a meta-analysis of randomized controlled trials (RCTs) to evaluate the use of vitamin D intervention on COVID-19 outcomes. Methods: Literature search was conducted using PubMed, Cochrane library, and ClinicalTrials.gov databases (latest search on August 5, 2021). We included RCTs reporting the use of vitamin D intervention to control/placebo group in COVID-19. Two independent researchers did literature search, abstracted data, and the risk of bias assessment. Results: A total of 6 RCTs with 551 COVID-19 patients were included. The overall collective evidence pooling all the outcomes across all RCTs indicated the beneficial use of vitamin D intervention in COVID-19 (relative risk, RR = 0.60, 95% CI 0.40 to 0.92, Z=2.33, p=0.02, I 2 = 48%). However, no statistical significance was observed for individual outcomes of ICU care (RR = 0.11, 95% CI 0.15 to 1.30, Z=1.48, p=0.14, I 2 = 66%) and mortality (RR = 0.78, 95% CI 0.25 to 2.40, Z=0.66, p=0.02, I 2 = 33%), though decreased rates were noted. The rates of RT-CR positivity was significantly decreased in the intervention group as compared to the non-vitamin D groups (RR = 0.46, 95% CI 0.24 to 0.89, Z=2.31, p=0.02, I 2 = 0%). Conclusion: COVID-19 patients supplemented with vitamin D are more likely to demonstrate fewer rates of ICU admission, mortality events and RT-PCR positivity. However, no statistical significance has been achieved for individual outcomes of ICU and deaths. More RCTs and completion of ongoing trials largely needed to precisely establish the association between vitamin D use and COVID-19.
Funding The costs involved in the conduction of this systematic review and meta-analysis were borne by the authors themselves.
Declaration of Competing Interest The authors declare no conflict of interest.
References
Alsafar, Grant, Hijazi, Uddin, Alkaabi et al., COVID-19 disease severity and death in relation to vitamin D status among SARS-CoV-2-positive UAE residents, Nutrients,
doi:10.3390/nu13051714Am, Mj, Mk, Vitamin D Status Is Associated With In-Hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients, Mayo Clin Proc,
doi:10.1016/J.MAYOCP.2021.01.001Da, Ca, Jd, Jf, Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(21)00051-6Ec, Ec, Vb, Ad, Lm, Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study, J Steroid Biochem Mol Biol,
doi:10.1016/J.JSBMB.2020.105751Gv, Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells, Biomedicines,
doi:10.3390/BIOMEDICINES8050129Jac, Mj, Ns, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ,
doi:10.1136/BMJ.L4898Kumar, Rathi, Haq, Wimalawansa, Sharma, Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19, Virus Res,
doi:10.1016/J.VIRUSRES.2020.198235Lakkireddy, Gadiga, Malathi, Karra, Raju et al., Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease, Sci Rep,
doi:10.1038/s41598-021-90189-4Moher, Liberati, Tetzlaff, Altman, Altman et al., Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, PLoS Med,
doi:10.1371/journal.pmed.1000097Mpw, Vitamin-D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients, Clin Chem Lab Med,
doi:10.1515/CCLM-2020-1567Murai, Fernandes, Sales, Pinto, Goessler et al., Effect of a Single High Dose of Vitamin D3on Hospital Length of Stay in Patients with Moderate to Severe COVID-19: A Randomized Clinical Trial, JAMA -J Am Med Assoc,
doi:10.1001/jama.2020.26848Mv, Tv, Ia, Sa, Vp, Low Circulating Vitamin D in Intensive Care Unit-Admitted COVID-19 Patients as a Predictor of Negative Outcomes, J Nutr,
doi:10.1093/JN/NXAB107Oa N, Shedding light on vitamin D: the shared mechanistic and pathophysiological role between hypovitaminosis D and COVID-19 risk factors and complications, Inflammopharmacology,
doi:10.1007/S10787-021-00835-6Phf, Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor?, Nutrients,
doi:10.3390/NU9070651Pl, Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies, J Steroid Biochem Mol Biol,
doi:10.1016/J.JSBMB.2021.105883Rastogi, Bhansali, Khare, Suri, Yaddanapudi et al., Short term, high-dose vitamin D supplementation for COVID-19 disease: A randomised, placebocontrolled, study (SHADE study), Postgrad Med J,
doi:10.1136/postgradmedj-2020-139065Rm, Mj, Sg, Jp, Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews, Int J Epidemiol,
doi:10.1093/IJE/DYS041Rr, Tl, An update on the association of vitamin D deficiency with common infectious diseases, Can J Physiol Pharmacol,
doi:10.1139/CJPP-2014-0352Sabico, Enani, Sheshah, Aljohani, Aldisi et al., Effects of a 2-week 5000 iu versus 1000 iu vitamin d3 supplementation on recovery of symptoms in patients with mild to moderate covid-19: A randomized clinical trial, Nutrients,
doi:10.3390/nu13072170Sk, Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors, Exp Gerontol,
doi:10.1016/J.EXGER.2021.111507Sánchez-Zuno, González-Estevez, Matuz-Flores, Macedo-Ojeda, Hernández-Bello et al., Vitamin D Levels in COVID-19 Outpatients from Western Mexico: Clinical Correlation and Effect of Its Supplementation, J Clin Med,
doi:10.3390/jcm10112378
